Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Titan Pharmaceuticals schedules pre-NDA meeting for Probuphine

Sep. 1, 2011

ALL-00179 allows transdermal delivery of cannabidiol with microneedles

Aug. 22, 2011

PharmAthene receives Department of Defense contract for nerve agent medical countermeasure program

Aug. 17, 2011

First specific treatment for scorpion stings approved in U.S.

Aug. 5, 2011

Heroin-like immunoconjugate protects against addiction

Aug. 2, 2011

Beta-adrenoceptor antagonist prevents retrieval of cocaine-associated memory in rats

July 28, 2011

Nabi Biopharmaceuticals reports on first confirmatory phase III NicVAX study

July 19, 2011

Titan Pharmaceuticals reports topline results from phase III Probuphine trial

July 13, 2011

Rectogesic slows lymphatic transit time of snake venom

July 12, 2011

New full dopamine D3 receptor agonist CJ-1639 displays potent and selective activity in vivo

July 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...